Prescott’s Inc. Announces Expansion into Anesthesia Specialty Service with Acquisition of Heartland Medical Sales & Service

Prescott’s, Inc. (“Prescott’s”), the leading provider of refurbishment, maintenance, repair and service work for surgical microscopes utilized in hospital operating rooms and ambulatory surgery centers and a portfolio company of Atlantic Street Capital (“ASC”), announced today its expansion into the anesthesia specialty service and support sector with the acquisition of Heartland Medical Sales & Service (“Heartland”).

Founded in 1998 by Bradly Rumph and headquartered in Louisville, KY, Heartland focuses on delivering reliable service, repair, refurbishment and sales of anesthesia machines and related equipment. As Heartland has grown, their equipment capabilities have expanded as well to include single replacement devices to the complete outfitting of surgery centers and other medical facilities and equipment rental, refurbishment, and repair services. Heartland remains dedicated to its roots as a service company which is a natural extension of Prescott’s business.

Dylan DiJulio, Chief Executive Officer of Prescott’s, commented, “We are thrilled to have Heartland join the Prescott’s family.  This will allow us to continue to provide our clients with superior technical service and support of specialized surgical equipment nationwide while expanding our service offering to a broader product expertise. The anesthesia category is a natural extension of our business given the operational similarity and highly specialized skill required to provide field service support and repair and reconditioning capabilities. Brad Rumph has built an impressive company perfectly aligned with our service focused model. We believe our existing client base will welcome the additional capabilities that further differentiate us as a market leader.”

Brad Rumph, President and co-founder of Heartland, said, “For nearly 25 years, our mission at Heartland has been to serve as a trusted service partner to healthcare providers to ensure their medical equipment is reliable, safe, and always operational. We are proud of our tech staff and entire team who now look forward to being a part of Prescott’s and helping to expand this natural extension of their business.”

Prescott’s investment in Heartland represents the first of several anticipated acquisitions in the anesthesia refurbishment, maintenance, repair and service sector as well as other related contractual outsourced service, repair and maintenance business models serving the hospitals, integrated delivery networks (IDNs), surgery centers and specialty practice environments.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”